Advertisement

Topics

A novel combined process for efficient removal of Se(VI) from sulfate-rich water: Sulfite/UV/Fe(III) coagulation.

08:00 EDT 4th August 2018 | BioPortfolio

Summary of "A novel combined process for efficient removal of Se(VI) from sulfate-rich water: Sulfite/UV/Fe(III) coagulation."

The efficient removal of Se(VI) from sulfate-rich water is challenging as most reported processes last for hours to days. In this study, a combined sulfite/UV/Fe(III) coagulation process was proposed for efficient Se(VI) removal from sulfate-rich water within a short time (∼1 h). In the presence of sulfate (1000 mg L), over 99% of Se(VI) (initially at 10 mg L) could be reduced by sulfite (5.0 mM) with a UV dose of 16 J cm (within 20 min) into Se(IV) as the sole observed product. An alkaline pH (>9) was required for the reduction process, which was naturally obtained with the addition of sulfite. Scavenging experiments with NO and NO both indicated that hydrated electrons (e) were responsible for Se(VI) reduction by sulfite/UV. The presence of chloride, sulfate, phosphate, and carbonate (up to 10 mM) showed negligible influence on Se(VI) reduction, whereas nitrate and humic acid inhibited Se(VI) reduction to different extents depending on their concentrations. By Fe(III) coagulation, Se(IV) in the co-presence of sulfite and sulfate was efficiently removed at an OH/Fe molar ratio of 1.8-2.8. The removal of Se(IV) by Fe(III) coagulation responded insignificantly to chloride, nitrate, or sulfate (up to 10 mM), whereas it was adversely affected at high levels of carbonate (10 mM) and phosphate (1 mM). The combined sulfite/UV/Fe(III) coagulation process was validated for the efficient removal of Se(VI) from synthetic sulfate-rich solution, simulated wastewater, and authentic smelting wastewater (in 1.1 h). The introduced sulfite underwent minor consumption during UV irradiation and was almost (∼90%) removed after coagulation.

Affiliation

Journal Details

This article was published in the following journal.

Name: Chemosphere
ISSN: 1879-1298
Pages: 867-874

Links

DeepDyve research library

PubMed Articles [15514 Associated PubMed Articles listed on BioPortfolio]

Corrigendum to "Heavy metal and sulfate removal from sulfate-rich synthetic mine drainages using sulfate reducing bacteria" Sci. Total Environ. 635 (2018) 1308-1316.

Fast and efficient removal of As(III) from water by CuFeO with peroxymonosulfate: Effects of oxidation and adsorption.

Although oxidation of As(III) to As(V) is deemed necessary to promote arsenic removal, the oxidation process usually involves toxic byproducts, well-defined conditions, energy input or sludge generati...

Efficient and rapid removal of EDTA-chelated Pb(II) by the Fe(III)/flue gas desulfurization gypsum (FGDG) system.

This study introduces the application of the Fe(III)/flue gas desulfurization gypsum (FGDG) system to remove EDTA-chelated Pb(II). Systematic experiments were conducted to explore the possibility of r...

A novel sulfate removal process by ettringite precipitation with aluminum recovery: Kinetics and a pilot-scale study.

A novel sulfate removal process via ettringite precipitation was developed by dissolving ettringite and recycling Al under low pH condition. Effects of solid to liquid ratios, pH and temperature on et...

How to tackle the stringent sulfate removal requirements in mine water treatment-A review of potential methods.

Sulfate (SO) is a ubiquitous anion in natural waters. It is not considered toxic, but it may be detrimental to freshwater species at elevated concentrations. Mining activities are one significant sour...

Clinical Trials [6011 Associated Clinical Trials listed on BioPortfolio]

Use of Plasma Rich in Growth Factors (PRGF) in Pilonidal Sinus Excision

The use of plasma rich in growth factors in wound excision pilonidal sinus could improve the healing process of the wound, when compared with the usual technique of daily local healing. Th...

Combined Nutritional and Exercise Strategies to Reduce Liver Fat Content in Patients With Type 2 Diabetes

The aim of this study will be to evaluate in patients with type 2 diabetes the effects on liver fat of an intervention with a diet relatively rich in CHO/rich in fibre/low GI or a diet ric...

Platelet Rich Plasma During Radical Prostatectomy

Can platelet rich plasma applied to nerve bundles at time of surgery help the nerve bundles heal? Subjects undergoing a Radical Prostatectomy who meet study inclusion/exclusion criteria wi...

Metabonomics to Investigate Effects of Healthy Diets on Blood Pressure: the OmniHeart Study

To compare the urinary metabolomes on individuals undergone three different healthy diets--a carbohydrate-rich diet, a protein-rich diet, or a diet rich in unsaturated fat.

Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery

The investigators plan to compare three different devices that are used to break up large kidney stones during surgery for removal to see if one is faster or more efficient than the others...

Medical and Biotech [MESH] Definitions

3'-Phosphoadenosine-5'-phosphosulfate. Key intermediate in the formation by living cells of sulfate esters of phenols, alcohols, steroids, sulfated polysaccharides, and simple esters, such as choline sulfate. It is formed from sulfate ion and ATP in a two-step process. This compound also is an important step in the process of sulfur fixation in plants and microorganisms.

Derivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B (beta heparin; DERMATAN SULFATE) is a misnomer and this compound is not a true chondroitin sulfate.

An enzyme that catalyzes the activation of sulfate ions by ATP to form adenosine-5'-phosphosulfate and pyrophosphate. This reaction constitutes the first enzymatic step in sulfate utilization following the uptake of sulfate. EC 2.7.7.4.

An arylsulfatase that catalyzes the hydrolysis of the 4-sulfate groups of the N-acetyl-D-galactosamine 4-sulfate units of chondroitin sulfate and dermatan sulfate. A deficiency of this enzyme is responsible for the inherited lysosomal disease, Maroteaux-Lamy syndrome (MUCOPOLYSACCHARIDOSIS VI). EC 3.1.6.12.

An enzyme that specifically cleaves the ester sulfate of iduronic acid. Its deficiency has been demonstrated in Hunter's syndrome, which is characterized by an excess of dermatan sulfate and heparan sulfate. EC 3.1.6.13.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Searches Linking to this Article